logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Melinda Gooderham

queen's university
H指数:58
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Evidence of Upadacitinib in Atopic Dermatitis after Inadequate Response or Intolerance to Dupilumab: The CAN UpTIMISE Study

奥马帕尼布在特应性皮炎中的应用：在双卢木单抗治疗反应不佳或耐受性差后的真实世界证据：CAN UpTIMISE研究

Dermatology and Therapy
IF4.2
2026-09-110
OAAI
Vimal H. Prajapati; Vipul Jain; Melinda J. Gooderham; Michael Cecchini; Jason K. Lee; Charles W. Lynde; Parbeer Grewal; Andrew Ferrier; David Préfontaine; Carly Sterling; H. Chih-ho Hong
Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCE 1 and 2 Phase 3 Trials

艾克罗金拉通过1年的安全性：用于治疗中重度斑块状银屑病及影响高影响部位银屑病：ICONIC-LEAD、ICONIC-TOTAL和ICONIC-ADVANCE 1和2期3期试验的合并结果

Dermatology and Therapy
IF4.2
2026-08-280
OA
Mark G. Lebwohl; Melinda Gooderham; Richard B. Warren; Lawrence F. Eichenfield; Jessica H. Rubens; Tracy Cardillo; Christopher Russo; Cynthia M. C. DeKlotz; Megan Miller-Kassamali; Luis Anaya Velarde; Ming-Chun Hsu; Shu Li; Ya-Wen Yang; Sarah Ofori; Robert Bissonnette; Jennifer Soung; Adelaide A. Hebert; Linda Stein Gold
Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings

高影响部位银屑病对依库珠单抗的应答持久性：1年ICONIC-TOTAL研究数据

Journal of the European Academy of Dermatology and Venereology
IF8
2026-05-230
OAAI
Richard B. Warren; Melinda Gooderham; Edward Lain; Robert Bissonnette; Yu-Huei Huang; Julien Ringuet; Matthias Hoffmann; Andreas Pinter; Joseph F. Merola; Jessica H. Rubens; Dorothy Fan; Ming-Chun Hsu; Shu Li; Ya-Wen Yang; Cynthia M. C. DeKlotz; Eingun James Song
Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial

在DELTA 2随机、安慰剂对照、双盲、III期试验中，重度慢性手湿疹患者使用最大剂量德格利珠乳膏时的最小系统性暴露

Dermatology and Therapy
IF4.2
2026-05-170
OAAI
Melinda Gooderham; Christopher G. Bunick; JiaDe Yu; Douglas Maslin; Shannon K. R. Schneider; Marie Louise Østerdal; Anders Søhoel; Daniel Elenius Madsen; Lawrence F. Eichenfield
Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial

zasocitinib（TAK-279），一种高选择性口服TYK2抑制剂，在患有中重度斑块状银屑病患者的皮肤清除中表现出效：一项随机IIb期试验的事后分析

Dermatology and Therapy
IF4.2
2026-05-160
OA
Nada Elbuluk; April W. Armstrong; Ronald Vender; Tina Bhutani; Lawrence Green; Laura K. Ferris; Vivian Laquer; Angela Moore; Jamie Weisman; Wenwen Zhang; Warren Winkelman; Melinda J. Gooderham
Long-term efficacy of abrocitinib in patients with moderate-to-severe atopic dermatitis to 2 years

中重度特应性皮炎患者中阿布昔替尼的长期疗效长达2年

Journal of the European Academy of Dermatology and Venereology
IF8
2026-04-280
OAAI
Melinda J. Gooderham; Jonathan I. Silverberg; Marjolein De Bruin-Weller; Leon Kircik; Diamant Thaçi; Zuotao Zhao; Fernando Valenzuela; Toshifumi Nomura; Andrew Selfridge; Dorothy Fan; Daniela E. Myers; Pinaki Biswas; Saleem A. Farooqui; Melissa Watkins; Herwig Koppensteiner
Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary

使用0.15%罗氟司特乳膏长期治疗≥6岁特应性皮炎患者（INTEGUMENT-OLE临床研究）：一份通俗语言摘要

Journal of Dermatological Treatment
IF3.9
2026-01-010
PRE
Eric Lawrence Simpson; Lawrence F. Eichenfield; Kim Alexander Papp; Seth B. Forman; Adelaide Ann Hebert; Mercedes E. González; Melinda Gooderham; Chih-ho Hong; Vimal H. Prajapati; Emma Guttman‐Yassky; Jonathan I. Silverberg; Melissa S. Seal; David A. Krupa; Erin Almaraz; Diane Hanna; Patrick E. Burnett; Scott Snyder; Robert C. Higham; David R. Berk
Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary

罗氟司特泡沫与赋形剂泡沫治疗脂溢性皮炎（STRATUM临床研究）：一份简明语言摘要

Journal of Dermatological Treatment
IF3.9
2026-01-010
PRE
Andrew Blauvelt; Zoe Diana Draelos; Linda Stein Gold; Javier Alonso‐Llamazares; Neal D Bhatia; Janet C. DuBois; Seth B. Forman; Melinda Gooderham; Lawrence J. Green; Scott Guenthner; Adelaide Ann Hebert; Edward Lain; Angela Yen Moore; Kim Alexander Papp; Matthew Zirwas; Saori Kato; Scott Snyder; David A. Krupa; Patrick E. Burnett; David R. Berk
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial

研究摘要：Apremilast在日本掌跖脓疱病患者中的疗效：一项随机、III期临床试验

Dermatology and Therapy
IF4.2
2025-12-130
OAAI
Tadashi Terui; Yukari Okubo; Satomi Kobayashi; Akimichi Morita; Shinichi Imafuku; Yayoi Tada; Masatoshi Abe; Bruce Strober; Melinda Gooderham; Yasuhito Hara; Wendy Zhang; Junichiro Shimauchi; Masafumi Yaguchi; Takeshi Kimura; Ryuichi Ogawa; Hamid Amouzadeh; Masamoto Murakami
Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial

Apremilast在日本掌跖脓疱病患者中的疗效：一项随机、III期临床试验

Journal of the European Academy of Dermatology and Venereology
IF8
2025-11-260
OAAI
Tadashi Terui; Yukari Okubo; Satomi Kobayashi; Akimichi Morita; Shinichi Imafuku; Yayoi Tada; Masatoshi Abe; Bruce Strober; Melinda Gooderham; Wendy Zhang; Junichiro Shimauchi; Masafumi Yaguchi; Takeshi Kimura; Ryuichi Ogawa; Hamid Amouzadeh; Masamoto Murakami

研究方向

暂未获取到该数据
K
Kim Papp
H 指数:106论文数:818被引数:4.9万
C
Charles Lynde
H 指数:63论文数:415被引数:1.4万
A
Andrew Blauvelt
H 指数:92论文数:809被引数:3.7万
R
Ronald Vender
H 指数:34论文数:237被引数:4,577
J
Jonathan I. Silverberg
H 指数:99论文数:1,249被引数:5.0万
V
Vimal H. Prajapati
H 指数:18论文数:189被引数:1,818
I
Irina Turchin
H 指数:16论文数:81被引数:733
C
Chih-ho Hong
H 指数:11论文数:57被引数:656
R
Robert Bissonnette
H 指数:72论文数:471被引数:1.7万
M
Mark Lebwohl
H 指数:120论文数:1,415被引数:5.5万